The GA-map® COVID-19 reagent kit

The GA-map® Covid fecal test reagent kit is an CE-IVD documented test designed for use in molecular labs. The reagent kit is produced in our ISO 13485 certified facilities in Oslo, Norway. The reagent kit has been documented to reliably detect SARS-CoV-2 in fecal samples. The assay is a qPCR assay designed in compliance with US-CDC guidelines and recommendations for detection of SARS-CoV-2.

Key advantages with the GA-map® COVID-19 Fecal Test:

  • Fast and accurate detection of SARS-CoV-2 RNA presence in fecal sampling using robust RT-PCR technology
  • The technology for the test can be set up at any laboratory or samples can be sent to the GA service laboratory
  • Prolonged detection period of positive samples compared to nasopharyngeal specimens  
  • Instrumental part of the multiple specimens testing strategies: help to reduce false negative results

Requires the routine diagnostic laboratory to implement the GA-map® Technology platform and established the GA-map® Test. Fecal samples are locally collected and analyzed by the laboratory. GA will continuously provide CE-marked and validated reagents kit.

Anita Patel Jusnes – Chief Commercial Officer

Please contact me for more information

Get in touch